The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression

Abstract

Background The role of FDG–PET for managing patients with plexiform neurofibromas (PN) is unclear. While many PN tumors exhibit periods of rapid growth, others grow slowly or unpredictably and may have periods of relative quiescence. The ability to predict which PN are likely to progress should facilitate a more timely initiation of medical treatments… (More)
DOI: 10.1007/s11060-007-9501-5

Topics

5 Figures and Tables

Cite this paper

@article{Fisher2007TheRO, title={The role of [18F]-fluorodeoxyglucose positron emission tomography in predicting plexiform neurofibroma progression}, author={Michael J. Fisher and Sandip K. Basu and Eva Dombi and Jian Qin Michael Yu and Brigitte C Widemann and Avrum N. Pollock and Avital Cnaan and Hongming Zhuang and Peter C. B. Phillips and Abass Alavi}, journal={Journal of Neuro-Oncology}, year={2007}, volume={87}, pages={165-171} }